Hyung J. Ahn
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
A T7 autogene-mediated DNA vaccine platform for SARS-CoV-2: Overcoming DNA vaccine limitations with enhanced spike mRNA production.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: December 11, 2024
siRNA Nanoparticle Targeting PD-L1 Activates Tumor Immunity and Abrogates Pancreatic Cancer Growth in Humanized Preclinical Model.
Journal: Cells
Published: August 31, 2021
PLGA Nanoparticles Codelivering siRNAs against Programmed Cell Death Protein-1 and Its Ligand Gene for Suppression of Colon Tumor Growth.
Journal: Molecular pharmaceutics
Published: October 26, 2019
Cytoplasmic expression of EGFR shRNA using a modified T7 autogene-based hybrid mRNA/DNA system induces long-term EGFR silencing and prolongs antitumor effects.
Journal: Biochemical pharmacology
Published: October 25, 2019
CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer.
Journal: Gynecologic oncology
Published: August 25, 2019
KSP siRNA/paclitaxel-loaded PEGylated cationic liposomes for overcoming resistance to KSP inhibitors: Synergistic antitumor effects in drug-resistant ovarian cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 14, 2019
Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers.
Journal: Genome biology
Published: April 09, 2019
Systemic delivery of Eg5 shRNA-expressing plasmids using PEGylated DC-Chol/DOPE cationic liposome: Long-term silencing and anticancer effects in vivo.
Journal: Biochemical pharmacology
Published: March 15, 2019
Anti-EpCAM-conjugated adeno-associated virus serotype 2 for systemic delivery of EGFR shRNA: Its retargeting and antitumor effects on OVCAR3 ovarian cancer in vivo.
Journal: Acta biomaterialia
Published: November 27, 2018
Last Updated: 09/26/2026